Sotio Biotech, a clinical-stage biopharmaceutical company owned by PPF Group, promoted Vivi Boura, M.D., Ph.D., an oncologist with experience leading the clinical development of novel cancer therapies, to chief medical officer. Boura joined Sotio in 2021 as a medical director, after which she assumed roles of increasing responsibility in the leadership of Sotio’s clinical development team before being named deputy chief medical officer in February 2025.  As deputy CMO, she facilitated...